Human α-1-acid Glycoprotein Inhibits TNF Production in the CNS of Rabbits with Meningitis: A Report of Preliminary Observations

[1]  G. Kaplan,et al.  A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. , 1998, The Journal of infectious diseases.

[2]  K. Olsen,et al.  The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis. , 1997, The Journal of infectious diseases.

[3]  D D Breimer,et al.  The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.

[4]  D. F. Moore,et al.  Alpha-1-Acid (AAG, Orosomucoid) Glycoprotein: Interaction with Bacterial Lipopolysaccharide and Protection from Sepsis , 1997, Inflammation.

[5]  Gilla Kaplan,et al.  Selection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity , 1996, Molecular medicine.

[6]  G. Kaplan,et al.  Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis. , 1995, Microbial pathogenesis.

[7]  M. Krakowiak,et al.  Acute phase proteins in serum and cerebrospinal fluid in the course of bacterial meningitis. , 1995, Clinical biochemistry.

[8]  R. van Furth,et al.  High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Peter Brouckaer.  Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality , 1994, The Journal of experimental medicine.

[10]  G. Constantin,et al.  Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide , 1993, The Journal of experimental medicine.

[11]  D. Golenbock,et al.  Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide , 1993, Infection and immunity.

[12]  P. Bories,et al.  α1‐Acid glycoprotein potentiates lipopolysaccharide‐induced secretion of interleukin‐1 β, interleukin‐6 and tumor necrosis factor‐α by human monocytes and alveolar and peritoneal macrophages , 1992 .

[13]  G. Mccracken,et al.  The role of corticosteroid therapy in children with pneumococcal meningitis. , 1991, American journal of diseases of children.

[14]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[15]  K. Olsen,et al.  The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. , 1991, The New England journal of medicine.

[16]  S. Pomeroy,et al.  Seizures and other neurologic sequelae of bacterial meningitis in children. , 1990, The New England journal of medicine.

[17]  O. Ramilo,et al.  Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. , 1990, The Journal of pediatrics.

[18]  O. Ramilo,et al.  Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. , 1989, The Journal of pediatrics.

[19]  P. Meltzer,et al.  Alpha‐globulins suppress human leukocyte tumor necrosis factor secretion , 1989, European journal of immunology.

[20]  S. Stewart,et al.  Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. , 1988, The New England journal of medicine.

[21]  J. Kremer,et al.  Drug binding to human alpha-1-acid glycoprotein in health and disease. , 1988, Pharmacological reviews.

[22]  P. Forsberg,et al.  Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseases , 1987, Acta neurologica Scandinavica.

[23]  H. Neijens,et al.  Bacterial meningitis: Mechanisms of disease and therapy , 2005, European Journal of Pediatrics.

[24]  H. Yap,et al.  Inflammatory response in bacterial meningitis: cytokine levels in the cerebrospinal fluid. , 1995, Annals of tropical paediatrics.

[25]  B. Beutler,et al.  Lipopolysaccharide Signal Transduction, Regulation of Tumor Necrosis Factor Biosynthesis, and Signaling by Tumor Necrosis Factor Itself , 1995, Journal of cardiovascular pharmacology.

[26]  B. Oberg,et al.  Adjunctive corticosteroid therapy in bacterial meningitis. , 1995, Scandinavian journal of infectious diseases.

[27]  L. Chauvelot‐Moachon,et al.  In vivo, interleukin 1 and tumor necrosis factor alpha are essential cytokines involved in the induction of rat alpha 1-acid glycoprotein. , 1989, Progress in clinical and biological research.

[28]  N. Girgis,et al.  Levels of individual serum and cerebrospinal fluid proteins in purulent and tuberculous meningitis. , 1981, European neurology.

[29]  M. Kristensen,et al.  Serum orosomucoid in ulcerative colitis: its relation to clinical activity, protein loss, and turnover of albumin and IgG. , 1976, Scandinavian journal of gastroenterology.